Company profile

EKTAH

Nouvelles solutions nutritionnelles pour réduire la prise de poids corporel humaine et animale

Industry
Biotechnology Research
Employees
3
Headquarters
Dijon
Founded
2021
Office locations
1

EKTAH company summary

EKTAH is a company in the Biotechnology Research industry, headquartered in Dijon, founded in 2021. On LinkedIn the company has around 3 employees.

What technology does EKTAH use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About EKTAH

The Company’s proprietary platform targets fat taste receptors (CD36 and GPR120) — a novel mechanism that naturally stimulates the body’s endogenous release of satiety hormones including GLP-1, CCK, and PYY, without the need for exogenous hormone administration. This approach directly addresses the key limitations of current GLP-1 therapies: weight rebound after discontinuation, loss of lean muscle mass, and gastrointestinal side effects. Preclinical data demonstrate up to 40% reduction in food intake in obese animal models and 50% reduction in post-semaglutide weight rebound. Clinical data from 87+ subjects show a favorable safety profile with no serious adverse events. The Company’s pipeline includes two lead molecules (NKS-3 and NKS-5) for obesity, an anti-inflammatory program, and next-generation agonists in early development. EktaH is ISO 9001:2015 certified and is supported by an international Scientific Advisory Board. Founded in 2021, EktaH is headquartered in Dijon, France.

Where is EKTAH located?

EKTAH lists 1 location.

Dijon, 21000, FRHQ
6 boulevard Gabriel

Compare companies similar to EKTAH

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
EKTAH
ektah.com
Biotechnology Research32021Dijon
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about EKTAH

What does EKTAH do?

The Company’s proprietary platform targets fat taste receptors (CD36 and GPR120) — a novel mechanism that naturally stimulates the body’s endogenous release of satiety hormones including GLP-1, CCK, and PYY, without the need for exogenous hormone administration. This approach directly addresses the key limitations of current GLP-1 therapies: weight rebound after discontinuation, loss of lean muscle mass, and gastrointestinal side effects. Preclinical data demonstrate up to 40% reduction in food intake in obese animal models and 50% reduction in post-semaglutide weight rebound. Clinical data from 87+ subjects show a favorable safety profile with no serious adverse events. The Company’s pipeline includes two lead molecules (NKS-3 and NKS-5) for obesity, an anti-inflammatory program, and next-generation agonists in early development. EktaH is ISO 9001:2015 certified and is supported by an international Scientific Advisory Board. Founded in 2021, EktaH is headquartered in Dijon, France.

How many employees does EKTAH have?

EKTAH has around 3 employees on LinkedIn.

Where is EKTAH headquartered?

EKTAH is headquartered in Dijon.

When was EKTAH founded?

EKTAH was founded in 2021.

Build a lead list from companies like EKTAH

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.